Scholar Rock (SRRK)

• Market cap: $2.87B
• 1 day: 2.08%
• 5 days: 2.61%
• 1 month: -19.76%
• 3 months: -21.02%
• 6 months: -9.21%
• Year to date: -32.34%
• 1 year: -0.33%
• 5 years: -23.19%
• 10 years: 92.77%
• Sector: Healthcare
• Industry: Biotechnology

About: Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

Employees: 196